ghg’s Creative Directors Canevari, Reed, and Hanna to Judge Global Awards
John Canevari, ghg’s EVP and Chief Creative Officer, will be a judge on the executive jury—a panel of chief creative officers from around the world—for the 2013 Global Awards. GHG’s Shelley Hanna, VP/Executive Creative Director, and Justin Reed, SVP/Creative Director will be first-time members of the grand jury, a group of 70 creative directors who will review and select the top healthcare advertising from around the world.
When asked about her thoughts of judging the 2013 awards show, Shelley stated, “I’m sure the entries will be outstanding and I’m looking forward to seeing creative solutions from various countries around the world.“
Justin agreed, adding, “I feel there has been a lot of interesting work put into the market this year, and I’m thrilled to see what has been submitted for the competition.“
Now in its 19th year, the Global Awards is one of the world’s largest and most recognized healthcare communications awards, showcasing creativity and innovation in 150 category entries, spanning regional, national, and continental boundaries. The 2013 awards ceremony will take place on November 15th in New York City and Sydney, Australia. For more information, please visit http://www.theglobalawards.com/.
Vogel Farina Announced as Finalist in MM&M Awards
After 2 rounds of scoring by more than 100 independent industry judges, ghg’s Vogel Farina was announced as a finalist in the 2013 MM&M Awards.
Vogel Farina’s entry, My NET Manager patient app, offers carcinoid cancer and neuroendocrine tumor patients a unique opportunity to track information and set reminders on their mobile device in order to better manage their condition.
The MM&M Awards is one of the most widely recognized award showcases in healthcare marketing. The 2013 award ceremony will take place October 2nd, in New York. For more information, please visit http://awards.mmm-online.com/.
ghg Chief Engagement Officer Erin Byrne to Speak at Point of Care Summit
On Wednesday, September 18, 2013, ghg’s Chief Engagement Officer Erin Byrne will make a presentation at the CBI Point of Care Summit in Philadelphia, PA. Erin’s presentation, Reach Patients Through Effective Physician Communication, will look the impact of the Affordable Care Act on physician interaction with patients, review trends in patient communications, and discuss methods and new approaches to drive better health outcomes. Erin will also participate on a panel about The Role of Point of Care in the Multi-Channel Marketing Mix.
The Point of Care Summit is designed for pharmaceutical professionals to explore strategies to enhance brand experience, improve customer loyalty by targeting patients and healthcare professionals, and increase ROI through effective point-of-care marketing. The summit will take place September 18-19, 2013, at the Loews Hotel in Philadelphia, PA. For more information, please visit www.cbinet.com/conference/pc13068.
ghg Australia Honored With Bronze Award at the ADSA Non-Profit 2013 Awards for Work on AMRRIC
On August2nd, 2013, ghg Australia was honored with a bronze award at the ADSA Non-Profit 2013 awards in Europe. The winning entry, Uluruff, was recognized in the "film section – environment" category of the awards showcase.
The Uluruff CSA TV commercial is currently a key element in raising awareness for AMRRIC (Animal Management in Rural and Remote Indigenous Communities), an organization dedicated to supporting the health of indigenous animals and their communities. The ultimate goal of the Uluruff commercial piece is to raise awareness for the organization while encouraging Web site visits and donations.
View the Uluruff CSA TV commercial at: http://adsafestival.com/2013/08/02/winner-2013-film/.
ADSA Non-Profit is an international non-profit and social advertising award festival, dedicated exclusively to social and public communications. Since its inception in 1993, it has been the festival’s mission to focus public opinion on various global social matters. For more information, please visit http://adsafestival.com/adspotaward/.
WG Consulting Receives Partnership for Health Award
On July 12, 2013, ghg’s WG Consulting received the "Partnership for Health" award by the UK’s PharmaTimes, for their development of an innovative partnership model with Astellas Pharma, Ltd.
The model created by WG for Astellas focuses on creating real partnerships that deliver measurable outcomes, which includes meeting patient needs, and gaining an understanding of how this will ultimately benefit the company and its partners.
Both Astellas and WG recognized that, in practice, partnership working often fails to deliver for both parties. Although common goals may be identified, companies tend to focus on their own agenda while mistrusting the intentions of the other party involved. This creates a lack of shared understanding and commitment---a partnership of necessity---and a failure to establish essential honesty, respect, accountability, and trust. WG and Astellas saw that, too often, questions are raised on what actually gets delivered when there is no focus on measurable outcomes, which leads to frustration on both sides.
Astellas commissioned WG to put together a partnership model to work with the UK’s National Health Service (NHS) commissioners that is based on tangible outcomes and focuses on patient need with a clear understanding of how delivering this will benefit major stakeholders. Once the model was built on a solid foundation, the focus shifted to shared delivery with emphasis on implementation. NHS commissioners are now able to provide leadership and vision, ensuring clinical engagement.
Within this model, Astellas utilizes their relationships with clinicians, providers, and supply specialists with disease-area knowledge, and seeks to be seen as the partner of choice in joint projects within the fields of urology and urogynecology. WG is responsible for project management and delivery of specialist commissioning tasks, and will ensure that both partners meet their commitments; the company remains a key partner in ongoing delivery, and believes this innovative approach and methodology for creating partnerships has potential to be used in wider disease areas, creating real partnerships with NHS commissioners wherever increased capability and capacity is required.
For more information, please visit